Now showing items 21-30 of 139
RhoC Induces Differential Expression of Genes Involved in Invasion and Metastasis in MCF10A Breast Cells
(Kluwer Academic Publishers; Springer Science+Business Media, 2004-03)
Inflammatory breast cancer (IBC) is the most deadly form of breast cancer in humans presumably due to its ability to metastasize from its inception. In our laboratory, overexpression of RhoC GTPase was observed to be ...
Instructions for Authors
(Kluwer Academic Publishers; Springer Science+Business Media, 2002-11)
Rapid Re-expansion of a Macroprolactinoma After Early Discontinuation of Bromocriptine
(Kluwer Academic Publishers; Springer Science+Business Media, 2000-11)
Prolactin (PRL)-secreting pituitary adenomas are the most common functioning pituitary tumors. Medical treatment with dopamine agonists is the therapy of choice for macroprolactinomas (≥10 mm). Withdrawal of bromocriptine ...
Pergolide As Primary Therapy for Macroprolactinomas
(Kluwer Academic Publishers; Springer Science+Business Media, 2000-12)
The objective of this study is to determine whether pergolide therapy is an effective modality for the de novo treatment of patients with macroprolactinomas. Twenty-two consecutive patients with macroprolactinomas were ...
Medical Management of Growth Hormone-Secreting Pituitary Adenomas
(Kluwer Academic Publishers; Springer Science+Business Media, 2002-06)
The primary treatment of acromegaly remains transsphenoidal adenomectomy, yet the tissue overgrowth of acromegaly often progresses following surgery, and responds to radiotherapy only after significant delay. Persistently ...
Acceptability of Diagnostic Tests for Breast Cancer
(Kluwer Academic Publishers; Springer Science+Business Media, 2003-05)
Purpose . To assess the acceptability of new non-invasive breast cancer diagnostic tests intended to triage women in need of biopsy.
Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium ‘Breast Cancer – the Development and Validation of New Therapeutics’
(Kluwer Academic Publishers; Springer, 2005-03)
Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
(Kluwer Academic Publishers; Springer Science+Business Media, 2004-01)
The epidermal growth factor system is a well characterized growth factor receptor pathway, the deregulation of which has been be associated with neoplastic growth. Overexpression or amplification of the epidermal growth ...